The Latest in Ankylosing spondylitis

Rheumatology News

Upadacitinib meets primary endpoints for improvement in ankylosing spondylitis and nonradiographic disease

October 14, 2021

Rheumatology News

Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studies

September 30, 2021

Rheumatology News

Early vs. late TNFi switch in AS patients associated with different risk factors

September 24, 2021

Rheumatology News

Real-world data generate debate on definition of flare in axial spondyloarthritis

September 22, 2021

Rheumatology News

Targeting IL-23 could still be important for axial spondyloarthritis treatment

September 20, 2021

Rheumatology News

European agency recommends two new adalimumab biosimilars

September 20, 2021

Rheumatology News

csDMARDs could add to TNF inhibitors’ benefits in SpA

September 16, 2021

Rheumatology News

No gender gap seen in ankylosing spondylitis prevalence, study finds

September 7, 2021

Rheumatology News

COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patients

July 21, 2021

Rheumatology News

Researchers follow development of axial SpA in first-degree relatives of patients

July 7, 2021

Rheumatology News

Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitis

July 1, 2021

Rheumatology News

TNF inhibitors have delayed effect on spondyloarthritis radiographic progression

June 11, 2021

Rheumatology News

Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases

May 25, 2021

Rheumatology News

Multiple studies highlight pandemic’s impact on patients with rheumatic disease

May 6, 2021

Rheumatology News

Boosting the presence of darker skin in rheumatology education

April 21, 2021